TMDX Q4 2021 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$10M+26.8% YoY

Gross Profit

$7M72.3% margin

Operating Income

-$11M-117.2% margin

Net Income

-$13M-131.0% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

+80.0%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$135M

Total Liabilities

$67M

Stockholders' Equity

$68M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$8M	+26.8%
Gross Profit	$7M	$5M	+44.7%
Operating Income	-$11M	-$6M	-92.1%
Net Income	-$13M	-$6M	-100.7%

Revenue Segments

Ocs Heart Product

$6M63%

Ocs Lung Product

$2M22%

Ocs Liver Product

$1M15%

Geographic Segments

UNITED STATES

$7M62%

Non Us And Uk

$4M38%